Vitamin D, Immune Function, Respiratory Infections and COVID-19: What Trials Found
What randomized trials and reviews found for vitamin D and respiratory infections, including COVID-19, by dose, baseline level and study design, and what official sources say.
Content last updated . This page has not been medically reviewed.
Evidence labels: established nutritional role / deficiency treatment, evidence in adequately nourished people, mixed, insufficient evidence, no good evidence of benefit.
Respiratory infections: what the trials found
| Source | Who and what | Result | Label |
|---|---|---|---|
| Individual-participant meta-analysis (BMJ, 2017) | 25 randomized trials, 11,321 people aged 0 to 95, vitamin D3 or D2 vs placebo | Risk of acute respiratory infection lower overall (adjusted odds ratio 0.88, 0.81 to 0.96). Stronger with daily or weekly dosing (0.81) and in people starting below 25 nmol/L (0.30); not seen with bolus doses (0.97) [1] | Mixed; benefit mainly in very low baseline levels |
| Updated meta-analysis (Lancet Diabetes Endocrinol, 2025) | 40 studies, 61,589 people | Odds ratio 0.94 (0.88 to 1.00), not statistically significant; no clear effect modification by age, baseline vitamin D status, dosing frequency or dose size [2] | Mixed; no clear overall protection |
| CORONAVIT (UK, 2022) | 6,200 people 16 and older not taking vitamin D, open-label; offered a blood test, then 800 or 3,200 IU a day for six months if below 75 nmol/L, vs no offer | No reduction in all-cause respiratory infection or COVID-19; for example, infection odds ratio 1.26 (0.96 to 1.66) at 800 IU and 1.09 (0.82 to 1.46) at 3,200 IU [4] | No benefit found with a test-and-treat approach |
Both meta-analyses found no difference in serious adverse events between vitamin D and comparison groups. [1][2] The 2017 analysis defined its low-level group as below 25 nmol/L, which is a very low range; effects in people with very low levels do not transfer to people with adequate levels, and the reverse. [1]
COVID-19 treatment studies
| Source | Who and what | Result | Label |
|---|---|---|---|
| Brazilian trial (JAMA, 2021) | 240 hospitalized adults with moderate to severe COVID-19, one oral dose of 200,000 IU vitamin D3 vs placebo | No significant reduction in length of stay; the authors said findings do not support this dose for treatment [5] | No benefit found |
| Meta-analysis of 9 trials (2023) | 1,586 COVID-19 patients | Lower ICU admission (risk ratio 0.59), other hospital and lab outcomes not significantly different [6] | Mixed |
| Meta-analysis of 16 trials (2024) | Adults with COVID-19 | Hospital stay shortened by about 1.2 days on average, with high heterogeneity [7] | Mixed; heterogeneous |
| Rapid evidence review (2021) | Observational and trial data | Evidence for prevention or treatment of COVID-19 described as inconclusive [8] | Insufficient evidence |
These reviews pooled different trial designs, doses and patient groups, which explains why they do not agree. A low blood level in someone who is ill is not proof that vitamin D caused the illness, and the rapid review noted that most studies were small and observational, with risk of bias, residual confounding and reverse causality. [8]
Where official sources stand
The NHS describes vitamin D's role as regulating calcium and phosphate for healthy bones, teeth and muscles, and recommends supplements for specific groups. [3] See Vitamin D intake levels. For the goal-level view, read Vitamin C, vitamin D and zinc for immunity and Immune wellness.Frequently asked questions
Does vitamin D prevent colds?
Results are mixed. A 2017 analysis found lower risk overall and a 2025 update found a smaller effect that was not statistically significant. [1][2]
Does vitamin D prevent COVID-19?
The UK CORONAVIT trial found no reduction in COVID-19 with a test-and-treat approach, and the NHS says there is not enough evidence to take it solely for this. [4][3]
Does vitamin D help people already in hospital with COVID-19?
A trial of one 200,000 IU dose found no shorter stay. Meta-analyses give mixed results. [5][6][7]
Who might benefit most?
The 2017 analysis found the clearest effect in people with very low starting levels (below 25 nmol/L). [1]
Is more vitamin D better for immunity?
Not shown. Bolus doses were not protective in the 2017 analysis, and very large yearly doses were linked with more falls and fractures in one trial. [1][9]
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Safety and who should ask first
- Very large doses. A trial of 500,000 IU once a year in older women found more falls and fractures than placebo. [9] Excess vitamin D can also raise blood calcium. See Vitamin D toxicity.
- Weak immune systems and autoimmune conditions. Ask your care team before adding supplements; see Immunodeficiency and autoimmune conditions.
- Medicines. Some medicines affect vitamin D levels. [10] See Medication interactions.
- Pregnancy and children. Ask the care team; the NHS gives separate vitamin D advice for babies and children. [3]
- Testing. Routine vitamin D testing is not recommended for everyone. [10]
- Symptoms. Severe or lasting infection symptoms need medical care, not supplements. For emergencies call 911 (US).
References
- Martineau et al. 2017. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. PMID 28202713. Read 2026-10-23.
- Jolliffe et al. 2025. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data. Lancet Diabetes Endocrinol. PMID 39993397. Read 2026-10-23.
- NHS (UK). Vitamin D. Page last reviewed 3 August 2020. Read 2026-10-22.
- Jolliffe et al. 2022. Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). BMJ. PMID 36215226. Read 2026-10-23.
- Murai et al. 2021. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA. PMID 33595634. Read 2026-10-23.
- Zaazouee et al. 2023. Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials. Naunyn Schmiedebergs Arch Pharmacol. PMID 36508011. Read 2026-10-23.
- Ghoreshi et al. 2024. Effect of vitamin D supplementation on clinical outcomes in adult patients with COVID-19: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Pharmacol Res Perspect. PMID 39350561. Read 2026-10-23.
- Raisi-Estabragh et al. 2021. Vitamin D and coronavirus disease 2019 (COVID-19): rapid evidence review. Aging Clin Exp Res. PMID 34118024. Read 2026-10-23.
- Sanders et al. 2010. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. PMID 20460620. Read 2026-10-23.
- MedlinePlus (US National Library of Medicine). Vitamin D Test. Read 2026-10-22.